Skip to main navigation Skip to search Skip to main content

A Combination Treatment Reduces Acne Severity and PIHP

    • Cosmetique Active International

    Project: Clinical Trial

    Project Details

    Description

    Acne is a chronic, inflammatory skin condition. It may cause scars and post-inflammatory hyperpigmentation (PIHP). PIHP frequently affects individuals with a phototype of IV or above.\[1\] PIHP is worsened by UV radiation, lasts for years and impacts the individual well-being.\[2, 3\] In an observational study, 1785 adults with a phototype ranging from IV to VI with acne and PIHP applied daily for 2 months a dermocosmetic and a tainted sunscreen product (DC, Effaclar® Duo (+); SS, Anthelios® Shaka Fluide SPF 50+, SS; both La Roche-Posay Laboratoire Dermatologique, France.
    StatusFinished
    Effective start/end date15/04/2028/02/21

    Collaborative partners

    Keywords

    • Skin Diseases
    • Pigmentation Disorders
    • Hyperpigmentation
    • Radiation-Protective Agents
    • Protective Agents
    • Physiological Effects of Drugs
    • Dermatologic Agents
    • Sunscreening Agents

    Fingerprint

    Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.